Project Grant R01MH138802
- The National Institute of Mental Health awarded the Research Foundation For Mental Hygiene, Inc. (operating through its New York State Psychiatric Institute division) $228,030 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to adapt and pilot test Individual Placement and Support (IPS), an evidence-based employment intervention, for young adults experiencing early psychosis in Uganda. The recipient will conduct extensive community engagement activities in Kampala to...
- The National Institute of Mental Health awarded The Rand Corporation $676,820 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to evaluate the decentralization and scale-up of integrated chronic care clinics in Malawi. The award funds a stepped-wedge cluster randomized trial that would permanently transition Malawi's HIV delivery platform—a network of 700 clinics serving over 900,000 clients—into full-time integrated chronic care facilities providing daily...
- The National Institute of Mental Health awarded the University of Texas at Austin $171,793 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test an interactive mobile health chatbot (IPC Trainer) designed to improve the cost-effectiveness and quality of interpersonal counseling delivery by non-specialists treating common mental disorders in community settings in Mozambique. The project addresses two persistent challenges in task-shifted mental...
- The National Institute of Mental Health awarded Miresource, Inc. $1.744 million on September 12, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop a longitudinal mental health monitoring platform that generates personalized care guides and treatment referrals. Miresource will integrate software solutions, curate mental health content, and employ artificial intelligence to create personalized guides and automate triage and referral recommendations. The project aims to...
- The federal Project Grant awarded to The Trustees of Columbia University in the City of New York, valued at $5,393,812, supports a longitudinal study investigating the impact of changes in social determinants of health (SDOH) on the mental health of adolescents and young adults (AYA) in South Africa during the COVID-19 pandemic. This research is funded through the Mental Health Research Grants program (CFDA 93.242) administered by the National Institute of Mental Health (NIMH). The study...
- The National Institute of Mental Health awarded $1.579 million to the Research Foundation For Mental Hygiene, Inc., operating as the New York State Psychiatric Institute, on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to fund basic neuroscience research into the circuit mechanisms by which early-life adversity produces sustained reward deficits. The research examines how childhood trauma—including abuse, neglect, and chronic stress—alters neural circuits governing...
- The National Institute of Mental Health awarded The Feinstein Institutes For Medical Research $460,625 on July 24, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct network analysis research on clinical high risk for psychosis populations. The award funds a research project examining the interplay of clinical symptoms, neurocognition, functioning, and stressful events in individuals at clinical high risk for developing psychosis using network theory. The research...
- The National Institute of Mental Health awarded The Trustees of Columbia University in the City of New York $534,191 on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop robust fine-mapping tools for genetic discovery in neuropsychiatric traits using deep phenotype data from diverse populations. The project addresses the challenge of understanding genetic causes of complex neuropsychiatric conditions including autism spectrum disorders, bipolar disorder, and...
- The National Institute of Mental Health awarded The Trustees of Columbia University in the City of New York $751,490 on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate a comprehensive resource package designed to accelerate adoption of clinical decision support systems for long-acting injectable HIV prevention and treatment medications in U.S. HIV clinics. The project addresses implementation barriers to long-acting injectables (LAI) for...
- The National Institute of Mental Health awarded Duke University $508,072 on May 18, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid type-2 effectiveness-implementation trial testing the integration of Sauti Ya Vijana (SYV, the Voice of Youth), a peer-led, group-based mental health treatment, within HIV clinical care for youth living with HIV in Tanzania and the United States. The award funds research designed to address the mental health treatment gap...
The National Institute of Mental Health awarded the Research Foundation For Mental Hygiene, Inc. (operating as New York State Psychiatric Institute) $1.248 million on August 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to implement evidence-based early intervention services for young people with untreated psychosis in Mozambique. The project, titled Mental Wellness Coordinated Specialty Care (MWELL-CSC) in Mozambique, develops and deploys a patient-centered digital mental wellness platform integrated with coordinated specialty care combining medication management and psychosocial interventions. The work addresses the absence of early intervention services for new-onset psychosis in low- and middle-income countries, where 80 percent of people developing psychosis reside and where duration of untreated psychosis is twice that in high-income countries. The recipient builds on established partnerships with the Mozambique Ministry of Health, local and global researchers, traditional healers, and community health committees operating across 64 rural primary care clinics. The intervention uses technology-based screening and community-based participatory service design to reduce duration of untreated psychosis, symptom severity, relapse, treatment discontinuation, hospitalization rates, and disability and caregiver burden, while improving social and occupational functioning. Performance occurs in Mozambique with administrative oversight in New York. The project period runs through July 31, 2031. The award is classified as a Project Grant, an assistance type supporting specified research projects.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/31/26 | ||
| Not listed | $186.0k | 8/24/26 | ||
| Not listed | $531.3k | 8/13/26 |